Mørkrid, Kjersti
Bogale, Binyam
Abbas, Eatimad
Abu Khader, Khadija
Abu Ward, Itimad
Attalh, Amjad
Awwad, Tamara
Baniode, Mohammad
Frost, Kimberly Suzanne
Frost, Michael James
Ghanem, Buthaina
Hijaz, Taghreed
Isbeih, Mervett
Issawi, Sally
Nazzal, Zaher A. S.
O’Donnell, Brian
Qaddomi, Sharif E.
Rabah, Yousef
Venkateswaran, Mahima
Frøen, J. Frederik http://orcid.org/0000-0001-9390-8509
Funding for this research was provided by:
European Research Council (Grant agreement number: 617639)
Research Council of Norway (Grant agreement number: 234376, Grant agreement number: 223269)
Article History
Received: 24 April 2020
Accepted: 16 December 2020
First Online: 11 January 2021
Ethics approval and consent to participate
: The study will be conducted according to the Palestinian MoH regulations and PNIPH research policies and procedures. All PHCs under study, intervention and control alike, have been notified by the MoH in Palestine about the research. Women are not required to give informed consent to be part of the health information system—the eRegistry, but they have to agree to receive text messages. Women in the sub-sample, to assess worries and perceptions of ANC, are required to give informed consent. This trial is considered non-medical health systems research and uses anonymous health data. Individuals are not regarded as research participants as all treatment decisions remain the responsibility of the healthcare professionals, and are not determined by the trial allocation [CitationRef removed]. The study protocols for the eRegCom trial and the sub-sample data collection have been approved by the ethics committee in Palestine, the Palestinian Health Research Council (401/18 and 670/19). The trial has received exemption from review by the Regional Committee for Health Research Ethics - Section South East B, Norway (2018/1148C).
: Not applicable.
: The authors declare that they have no competing interests.